The company will highlight expanded product offerings and other 3D applications in oncology, neuroscience, toxicity screening, and more. Corning experts will be able to speak to these applications, the impact of 3D in research and development and drug discovery, as well as perspectives in disease modeling and high-throughput screening.
Discussion topics will include how the use of physiologically relevant 3D cell cultures is facilitating discovery and validation of novel drug targets and accelerating clinical translation of drug candidate screening for safety and efficacy. Spokespeople will be available for tours and to share insights at booth #413.
Corning and its customers will also offer several presentations and posters during SLAS including: Presentations and Tutorials
• Sunday, February 3, 2019 Short Course: Set-up and Validation of 3D Primary, Stem Cell and Immortalized Cultures for Downstream Microplate Reader and Imaging Applications Presented by: Brad Larson, BioTek Instruments, Inc., Mark E. Rothenberg Ph.D., Corning ...
